In recent years, studies have found that KLF3, as a transcriptional repressor, is abnormally expressed in a variety of tumors, including colon cancer (10), breast cancer (11), lung cancer (12), pancreatic cancer (13), etc. KLF3 plays an important role in different tumor types. This evidence concerns the gene KLF3 and familial pancreatic carcinoma.